GOOD SAMARITAN MEDICAL CENTER — History
CCN 220111 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$300M
Latest Revenue (FY2022)
+4.5%
Revenue CAGR (3yr)
7.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $275M | $299M | $300M | +0.5% | +4.5% |
| Operating Expenses | $265M | $266M | $278M | +4.6% | +2.5% |
| Operating Margin | 3.8% | 11.0% | 7.4% | -32.7% | +39.4% |
| Net Income | $10M | $33M | $22M | -32.3% | +45.6% |
| Licensed Beds | 251 | 246 | 208 | -15.4% | -9.0% |
| Total Patient Days | 62,572 | 63,033 | 58,991 | -6.4% | -2.9% |
| Medicare Day % | 38% | 36% | 40% | +9.3% | +2.1% |
| Medicaid Day % | 12% | 14% | 14% | -1.3% | +8.1% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.1% ($275M → $300M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+4.5%
This Hospital
+7.6%
State Avg
Latest Margin
7.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $313M | 9.2% |
| FY2024 (proj) | $325M | 11.0% |
| FY2025 (proj) | $338M | 12.8% |